Pharmaniaga Bhd (XKLS:7081) Other Current Receivables: RM0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:7081 Pharmaniaga Bhd XKLS:7081
67 GF Score
Price RM1.16
GF Value RM1.12
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pharmaniaga Bhd Other Current Receivables?

Pharmaniaga Bhd XKLS:7081 -0.85% 67 Other Current Receivables is RM0 Mil as of Jun. 2026. GuruFocus rates XKLS:7081 with a GF Score™ of 67/100 and a GF Value™ of RM1.12 (Fairly Valued). The stock has 6 warning signs investors should review.

Pharmaniaga Bhd's Other Current Receivables for the quarter that ended in Jun. 2026 was RM0 Mil.

Pharmaniaga Bhd's quarterly Other Current Receivables declined from Dec. 2025 (RM19.47 Mil) to Mar. 2026 (RM0.00 Mil) but then stayed the same from Mar. 2026 (RM0.00 Mil) to Jun. 2026 (RM0.00 Mil).

Pharmaniaga Bhd's annual Other Current Receivables declined from Dec. 2023 (RM5.79 Mil) to Dec. 2024 (RM4.92 Mil) but then increased from Dec. 2024 (RM4.92 Mil) to Dec. 2025 (RM19.47 Mil).

Pharmaniaga Bhd Other Current Receivables Related Terms

Pharmaniaga Bhd Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Pharmaniaga Bhd's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaniaga Bhd Other Current Receivables Chart

Pharmaniaga Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.79 7.82 5.79 4.92 19.47

Pharmaniaga Bhd Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 19.47 0.00 0.00
XKLS:7081
67GF Score
Pharmaniaga Bhd XKLS:7081
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmaniaga Bhd Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of RM0 Mil mean?
Pharmaniaga Bhd (XKLS:7081) has a Other Current Receivables of RM0 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Pharmaniaga Bhd and its competitors.
Is Pharmaniaga Bhd's Other Current Receivables too high?
Pharmaniaga Bhd's current Other Current Receivables is RM0 Mil. Overall, Pharmaniaga Bhd has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's Other Current Receivables compare to MCK and COR?
Pharmaniaga Bhd's Other Current Receivables of RM0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Distribution company?
A good Other Current Receivables depends on the Medical Distribution industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Pharmaniaga Bhd and its competitors. Pharmaniaga Bhd's current Other Current Receivables is RM0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Fairly Valued. The stock's GF Value™ is RM1.12, compared to a current price of RM1.16 — trading 3.6% above its estimated fair value. The current Other Current Receivables is RM0 Mil. Pharmaniaga Bhd's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current Other Current Receivables is RM0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued. The current stock price of RM1.16 is trading 3.6% above its estimated GF Value™ of RM1.12. GuruFocus considers Pharmaniaga Bhd to be Fairly Valued.

Key valuation signals for XKLS:7081:

  • Other Current Receivables: RM0 Mil
  • GF Value™: RM1.12 vs. price of RM1.16 (3.6% above fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmaniaga Bhd Business Description

Address No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja, Seksyen 7, Selatan, Shah Alam, SGR, MYS, 40000
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
67GF Score

Get the complete analysis for XKLS:7081

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM1.16
Price
RM1.12
GF Value